专利检索 ap:("Matthias Keller" OR "Carina Mallard" OR "Hans-Peter Deigner" OR "David Enot" OR "Emeka I. Igwe") AND inv:"Emeka I. Igwe" 第 1 页

1.

发明申请
Method and Use of Metabolites for the Diagnosis of Inflammatory Brain Injury in Preterm Born Infants 审中-公开
标题翻译：代谢产物诊断早产儿炎症性脑损伤的方法与用途

公开(公告)号：US20140297195A1

公开(公告)日：2014-10-02

申请号：US14000931

申请日：2012-02-22

申请人： Matthias Keller , Carina Mallard , Hans-Peter Deigner , David Enot , Emeka I. Igwe

发明人： Matthias Keller , Carina Mallard , Hans-Peter Deigner , David Enot , Emeka I. Igwe

IPC分类号： G06F19/10 , G01N33/483

CPC分类号： G16B99/00 , G01N33/483 , G01N33/6896 , G01N2800/38

摘要： The present invention relates to novel biomarkers for predicting the likelihood of inflammation-related brain injury in preterm born infants, using a plurality of endogenous target metabolites selected from the group consisting of acyl carnitins, diacylphosphatidylcholines, acyl-alkylphosphatidylchoines, lysophosphatidylcholines and amino acids.

摘要翻译： 本发明涉及使用选自酰基肉毒碱，二酰基磷脂酰胆碱，酰基 - 烷基磷脂酰胆碱，溶血磷脂酰胆碱和氨基酸的多种内源性目标代谢物来预测早产儿婴幼儿发炎相关脑损伤的可能性的新型生物标志物。